(+/-)8,9-epetre

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 395 references associated with (+/-)8,9-epetre in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for (+/-)8,9-epetre

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (+/-)8,9-epetre

MeSH term MeSH ID Detail
Insulinoma D007340 28 associated lipids
Hyperemia D006940 25 associated lipids
Hypertension D006973 115 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Hyperhomocysteinemia D020138 6 associated lipids
Total 5

PubChem Biomolecular Interactions and Pathways

All references with (+/-)8,9-epetre

Download all related citations
Per page 10 20 50 100 | Total 86
Authors Title Published Journal PubMed Link
Kandhi S et al. EETs Elicit Direct Increases in Pulmonary Arterial Pressure in Mice. 2016 Am. J. Hypertens. pmid:26304959
Wang X et al. CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure. 2014 Mol. Pharmacol. pmid:24145329
Althurwi HN et al. Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy. 2014 J. Cardiovasc. Pharmacol. pmid:24157956
Diani-Moore S et al. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA. 2014 Drug Metab. Dispos. pmid:24311719
Strauss KI et al. Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury. 2013 Jul-Aug Prostaglandins Other Lipid Mediat. pmid:22922090
Cracowski JL et al. Involvement of cytochrome epoxygenase metabolites in cutaneous postocclusive hyperemia in humans. 2013 J. Appl. Physiol. pmid:23172029
Klett EL et al. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion. 2013 J. Biol. Chem. pmid:23766516
Liu Y et al. A soluble epoxide hydrolase inhibitor--8-HUDE increases pulmonary vasoconstriction through inhibition of K(ATP) channels. 2012 Pulm Pharmacol Ther pmid:22155000
Gao Y et al. 8,9-Epoxyeicosatrienoic acid inhibits antibody production of B lymphocytes in mice. 2012 PLoS ONE pmid:22802958
Norton SK et al. Epoxyeicosatrienoic acids are involved in the C(70) fullerene derivative-induced control of allergic asthma. 2012 J. Allergy Clin. Immunol. pmid:22664166

Table of Content